Latest Melanoma Stories
LONDON, December 12, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Melanoma Drugs - new study showing you trends,
SCIB1 continues to generate highly encouraging survival data; Modi-1 vaccine on track for 2016 entry into clinic NOTTINGHAM, England, December 10, 2014 /PRNewswire/ --
Study is the First to Evaluate Investigational Combination of an Oncolytic Immunotherapy and Anti-PD-1 Therapy THOUSAND OAKS, Calif., Dec.
When humans migrated out of Africa, the pigmentation in their skin gradually adapted to cooler climates resulting in the paler skin of people who now live in higher latitudes. But natural selection is furthering this adaptive process despite an increased risk of skin cancer.
The American Society for Dermatologic Society Association applauds the District of Columbia Council that voted unanimously Dec.
Immune-based brain cancer diagnostic for rapid, accurate disease classification SAN RAMON, Calif., Dec.
Cancer types such as melanoma, prostate cancer and certain types of leukemia weaken the body by over-activating the natural immune system. Researchers have now demonstrated that selenium – naturally found in, e.g., garlic and broccoli – slows down the immune over-response.
immunoSEQ(TM) Next Generation Sequencing Assay Confirms Presence of Active Immune Response in Responders Prior to Treatment SEATTLE, Nov.
Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PLYMOUTH MEETING, Pa., Nov. 20, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
- A transitional zone between two communities containing the characteristic species of each.
More Images (1 images) »